Enabling proactive care with early detection - providing timely interventions and better health outcomes for dogs.
The current blood diagnostic panels for pets cannot catch many illnesses such as early stage cancers, osteoarthritis, subclinical organ damage or early stage autoimmune disease.
As a result, many dogs may appear healthy in standard tests despite underlying health issues.
Our cell-free DNA (“cfDNA”) analysis protocol is designed to set the global standard in cfDNA testing. With our test, veterinarians gain a powerful, early-stage biomarker of general health that complements existing diagnostics (such as CRP) to support more informed treatment decisions.
By measuring cfDNA, veterinarians can detect underlying cell changes early - often before symptoms or abnormalities appear in traditional blood panels. This non-invasive, affordable tool aids in identifying issues such as cancer, organ damage, and chronic degeneration, enabling timely interventions that improve outcomes and support proactive, comprehensive care.
Your dog’s health and happiness are incredibly important, and proactive care is the best way to support their wellbeing. Our cfDNA test provides a simple, non-invasive way to detect underlying health issues before traditional biomarkers (such as CRP) show any signs.
This means you can catch serious conditions including cancer, organ damage, and chronic diseases earlier, giving you and your veterinarian the chance to take action sooner. Early detection can make all the difference in providing your dog with a longer, healthier, and happier life.